Open Journal of Gastroenterology

Volume 5, Issue 9 (September 2015)

ISSN Print: 2163-9450   ISSN Online: 2163-9469

Google-based Impact Factor: 0.48  Citations  

A Study on the Safety of Liver Biopsy Inpatients with Von Willebrand’s Disease

HTML  XML Download Download as PDF (Size: 226KB)  PP. 134-138  
DOI: 10.4236/ojgas.2015.59022    4,207 Downloads   4,699 Views  


Objectives: Liver biopsy remains the gold standard for diagnosis of chronic liver diseases. Outpatient percutaneous biopsy is generally safe with a mortality rate of 0.17% and hospitalization rate for bleeding of 3%. Von Willebrand disease (vWD) syndrome is the most common inherited hematological disorder with a prevalence of 1% - 3% globally. We sought to study whether vWD increases the risk of bleeding for liver biopsies. Methods: All patients (n = 120) who underwent outpatient percutaneous liver biopsies from 1997 to 2007 were analyzed. Demographics, PT/INR, platelet count, vW antigen and ristocetin induced platelet aggregation were studied. Results: No vWD patients had major bleeding that required transfusion, hospitalization or surgery but 9 (75%) had minor local bleeding and all had ecchymosis, which resolved spontaneously within 24 hours. Conclusions: Patients with vW factor deficiency can undergo percutaneous liver biopsy without major bleeding. Minor bleeding may occur at a slightly higher rate. vWD is not a contraindication to percutaneous liver biopsy.

Cite this paper

Basu, P. , Shah, N. , Aloysius, M. , Rayapudi, K. and Brown, R. (2015) A Study on the Safety of Liver Biopsy Inpatients with Von Willebrand’s Disease. Open Journal of Gastroenterology, 5, 134-138. doi: 10.4236/ojgas.2015.59022.

Cited by

No relevant information.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.